Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02096926 · ClinicalTrials.gov registry record · Phase 4
Methodological Validation of Ibuprofen Verses Placebo for Post Operative Pain After Third Molar Extraction Surgery
A Phase 4 study, sponsored by Lotus Clinical Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT02096926 is a Phase 4 study that has completed, run by Lotus Clinical Research. The registered enrollment target is 40 participants.
The verdict
NCT02096926, a Phase 4 study, has completed, sponsored by Lotus Clinical Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a single center placebo controlled, prospective, randomized study on healthy adults undergoing third molar surgery.
Interventions
- DRUG Placebo
- DRUG Ibuprofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-03 |
| Est. Completion | 2014-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02096926
The ClinicalTrials.gov registry entry for NCT02096926 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lotus Clinical Research, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02096926 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02096926 about?
NCT02096926 is a clinical study titled "Methodological Validation of Ibuprofen Verses Placebo for Post Operative Pain After Third Molar Extraction Surgery". This is a single center placebo controlled, prospective, randomized study on healthy adults undergoing third molar surgery.
What is the current status of trial NCT02096926?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2014-03. Estimated completion is 2014-05.
What interventions are being tested in trial NCT02096926?
The interventions under investigation include: Placebo (DRUG), Ibuprofen (DRUG).
Who is sponsoring clinical trial NCT02096926?
This trial is sponsored by Lotus Clinical Research, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.